Article

FDA-approved laser system treats high myopia with astigmatism

The FDA has granted approval for Advanced Medical Optics’ (AMO) STAR S4 IR excimer laser system for the treatment of high myopia and myopic astigmatism.

With the CustomVue wavefront-guided LASIK procedure, indications include the reduction or elimination of myopia and myopic astigmatism from –6 to –11 D with up to –3 D of cylinder. Clinical studies found that at 6 months, in 98.3% of those who received the CustomVue high-myopia treatment vision was corrected to 20/40 or better and in 84.3% it was corrected to 20/20 or better without spectacles or corrective contact lenses, according to AMO.

CustomVue procedures for high myopia will be released to doctors certified in VISX technology over the next several weeks after they have completed the training and certification process.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.